Dihexa
Lyophilized research reference material. Released with a per-lot Certificate of Analysis. For laboratory research use only.
- All products currently listed on this site are for research purposes ONLY.
- All products sold on this website are intended for research and identification purposes only.
- These products are not intended for human dosing, injections, or ingestion.
- Peptides are strictly for laboratory, academic, or institutional research and not for human or animal consumption.
Research background
Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is a synthetic small-molecule oligopeptide derivative of angiotensin IV, designed for metabolic stability and CNS penetration. Research describes interaction with the hepatocyte growth factor (HGF)/c-Met system and effects on synaptogenesis in preclinical models.
The data are preclinical (cell and rodent); dihexa is a research compound without an approved indication.
Summary of published scientific literature provided for laboratory research reference only. It is not a claim of safety, efficacy, or suitability for any use, and does not describe or recommend any human or veterinary use.
Selected references
- McCoy AT, et al. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. Journal of Pharmacology and Experimental Therapeutics. 2013;344(1):141-154.
- Benoist CC, et al. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on HGF/c-Met. Journal of Pharmacology and Experimental Therapeutics. 2014;351(2):390-402.
- Wright JW, Harding JW. The brain hepatocyte growth factor/c-Met receptor system. Journal of Alzheimer's Disease. 2015;45(4):985-1000.
Trademarks & attribution
Dihexa is a research compound (angiotensin IV analog) with no approved trademarked drug product. Catalyst Research Labs is not affiliated with any developer. Supplied as reference material only.
-
PeptidesRESEARCH USE ONLY COA 2–8°C
